Seeing Is Believing
IONS is currently covered by 13 analysts with an average price target of $62.37. This is a potential upside of $10.92 (21.22%) from yesterday's end of day stock price of $51.45.
Ionis Pharmaceuticals's activity chart (see below) currently has 172 price targets and 165 ratings on display. The stock rating distribution of IONS is 71.79% BUY, 7.69% SELL and 20.51% HOLD.
Analysts average stock forecasts to be materialized ratio is 54.08% with an average time for these price targets to be met of 161.88 days.
Highest price target for IONS is $85, Lowest price target is $28, average price target is $62.37.
Most recent stock forecast was given by JASON GERBERRY from BAML on 16-Jul-2024. First documented stock forecast 12-Aug-2014.
Currently out of the existing stock ratings of IONS, 28 are a BUY (71.79%), 3 are a SELL (7.69%), 8 are a HOLD (20.51%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
67
$19.18 (40.11%)
62
10 days ago
1/7 (14.29%)
$17.16 (34.43%)
71
Hold
53
$5.18 (10.83%)
50
29 days ago
6/9 (66.67%)
$5.77 (12.22%)
76
Buy
60
$12.18 (25.47%)
60
1 months 23 days ago
0/10 (0%)
$21.23 (54.76%)
Buy
63
$15.18 (31.74%)
62
5 months 4 days ago
11/24 (45.83%)
$19.02 (43.25%)
270
Hold
55
$7.18 (15.01%)
41
5 months 25 days ago
2/3 (66.67%)
$4.03 (7.91%)
79
What is IONS (Ionis Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on IONS (Ionis Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on IONS (Ionis Pharmaceuticals)?
Which analyst is the currently most bullish on IONS (Ionis Pharmaceuticals)?
Which analyst is the currently most reserved on IONS (Ionis Pharmaceuticals)?